AMBOSS
AMBOSS is a Berlin-based digital medical knowledge platform serving 1M+ students, clinicians, and institutions across 180 countries through an integrated Knowledge Library, Qbank, and AI-powered clinical decision support, monetized via individual and institutional subscriptions.
- Company typePrivate
- Founded2012
- HeadquartersBerlin, Germany
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingSoftware
What AMBOSS does
AMBOSS is a digital medical knowledge platform founded in 2012 and headquartered in Berlin, with US operations through AMBOSS MD Inc. in New York. The company serves medical students, practicing clinicians, and healthcare educational institutions through a subscription product that combines a curated Knowledge Library of 20,000+ expert-reviewed medical topics with an integrated 4,100+ question Qbank covering USMLE, COMLEX, Shelf, PANCE, EOR, ANCC, and AANP exams. Specialized sub-products serve physician assistant and nurse practitioner students, while two 2024 acquisitions (NEJM Knowledge+ from NEJM Group and Novaheal) extend the platform into clinician board prep and nursing education respectively.
The platform is built on AWS and is delivered via web, native iOS and Android apps, Anki and Chrome extensions (including Quizlet integration), and a ChatGPT add-on. Its proprietary AI capability centers on LiSA 1.0, which powers AI Mode Learning (a generative AI study copilot) and AI Mode Clinical Care (point-of-care clinical decision support). LiSA 1.0 was ranked #1 among 31 AI systems in the Stanford-Harvard NOHARM Study for clinical care safety, outperforming board-certified internists by more than 15 percentage points and, in multi-agent configurations with Meta Llama 4 Scout and Google Gemini 2.5 Pro, reaching top-quartile safety performance approximately 6x more often.
AMBOSS monetizes through individual subscriptions priced $338–$448 for 3- to 12-month tiers and institutional licenses to medical schools, PA/NP programs, and residency programs (with named customers including Yale, Weill Cornell, UW Medicine, HCA Healthcare, Icahn Mount Sinai, NYU Grossman, University of Colorado, University of Maryland, UAB, and Duke), supported by a 5-day free trial and 30-day money-back guarantee. The company has raised approximately $298M in cumulative funding, with the most recent €240M round in March 2025 led by KIRKBI, M&G Investments, and Lightrock earmarked for technology investment, international expansion, and further acquisitions, and management has publicly signaled IPO preparation.
AMBOSS firmographics
Firmographics- Name
- AMBOSS
- Legal name
- AMBOSS SE
- Website
- https://amboss.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- AMBOSS is a Berlin-based digital medical knowledge platform serving 1M+ students, clinicians, and institutions across 180 countries through an integrated Knowledge Library, Qbank, and AI-powered clinical decision support, monetized via individual and institutional subscriptions.
- Ownership category
- akta.pro rank
AMBOSS industry classification
Industry- Product category
- Medical Education Software
- NAICS
- Educational Support Services (611710), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
- akta.pro secondary industry
- Nursing & Allied Health Certification Prep (CNA, EMT/Paramedic, Radiology, Sonography, PT/OT) (EDANAIAB)
Keywords
Where AMBOSS is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
AMBOSS business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Individual Subscriptions: Subscription-based access to the AMBOSS platform including Knowledge Library, Qbank, AI features, and clinical tools. Available in 1-month, 3-month, and 12-month terms with annual billing.
- Institutional Licensing: Campus and clinic licenses for medical schools, PA programs, NP programs, and residency programs. Provides group access with administrative dashboards and usage analytics.
- Group Discounts: Volume-based pricing for student groups, with discounts increasing based on number of registrants.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | 1-month Qbank access (billed annually) |
| Subscription | Pay-as-you-go | 3-month Qbank access |
| Subscription | Annual | 12-month Qbank access |
| Subscription | Pay-as-you-go | 6-month access |
| Subscription | Annual | Institutional/Campus Licenses |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels10 records
AMBOSS product offering
Product offeringCore offering
AMBOSS is a digital medical knowledge platform that combines a comprehensive Knowledge Library of 20,000+ expert-reviewed medical topics with an integrated Qbank of 4,100+ exam-preparation questions, AI-powered learning and clinical decision support tools (LiSA 1.0), and specialized offerings for medical students, physician assistant students, nurse practitioner students, and practicing clinicians. The platform supports USMLE, COMLEX, PANCE, ANCC, and board certification exam preparation alongside point-of-care clinical reference, distributed via web, mobile apps, and institutional licenses.
Product overview
AMBOSS is a unified medical education and clinical decision support platform that combines a comprehensive Knowledge Library with an integrated Qbank, AI-powered learning tools, and point-of-care clinical resources. The core platform consists of the AMBOSS Knowledge Library (20,000+ medical topics) and AMBOSS Qbank (4,100+ exam questions) connected through AI Mode Learning and AI Mode Clinical Care. Specialized sub-products serve PA Students (PANCE/EOR prep) and NP Students (ANCC/AANP prep), while add-ons including Anki integration, Chrome Extension, Clinical Decision Support Tools, Score Predictor, and Clinician Mode extend functionality. The platform has been expanded through acquisitions of NEJM Knowledge+ (clinical education) and Novaheal (nursing education). Users can access resources via web, iOS/Android mobile apps, and institutional licensing for medical schools and residency programs.
Differentiator
Problem solved
Functional benefit
Brands
- AMBOSS LiSA 1.0: AMBOSS AI Mode - AI clinical care and learning system that ranked #1 in the Stanford-Harvard NOHARM Study for clinical care safety.
- NEJM Knowledge+
- Novaheal
Products and services
- AMBOSS Knowledge Library A comprehensive digital medical library containing over 20,000 expert-authored and continuously updated medical topics across articles, illustrations, and multimedia content. Serves medical students, clinicians, PA/NP students, and faculty as the foundational knowledge base of the AMBOSS platform, with every Qbank question linked to relevant Knowledge Library content for seamless study-to-practice transitions.
- AMBOSS Qbank A question database of more than 4,100 case-based vignettes for USMLE Step 2 CK, Shelf exams, COMAT, PANCE, EOR, and basic science preparation, with realistic exam interfaces, detailed answer explanations, and performance tracking linked to the Knowledge Library. Targets medical students, PA students, and residents preparing for licensing and certification exams.
- AI Mode Learning An AI study copilot that helps learners turn natural-language questions and uploaded materials (notes, slides) into trusted explanations, targeted Qbank practice sessions, Anki card recommendations, and clear next-step study guidance. Built on the AMBOSS Knowledge Library and serves medical, PA, and NP students as a personalized learning assistant.
- AI Mode Clinical Care (LiSA 1.0) An AI-powered clinical decision support tool for practicing clinicians that provides evidence-based diagnostic and treatment guidance at the point of care. Backed by the AMBOSS Knowledge Library and ranked #1 in the Stanford–Harvard NOHARM Study for clinical care safety, serving physicians, residents, attendings, and advanced practice providers.
- AMBOSS for PA Students A specialized version of the AMBOSS platform tailored for physician assistant students, featuring Qbanks for PANCE and End of Rotation exams mapped to NCCPA and PAEA blueprints, clinical survival guides, and tools supporting both didactic and clinical year PA education.
- AMBOSS for NP Students A specialized version of the AMBOSS platform for nurse practitioner students, featuring ANCC and AANP certification Qbanks mapped to clinical-grade knowledge libraries, personalized study plans, and evidence-based clinical support tools.
- NEJM Knowledge+ A medical education product acquired from NEJM Group and integrated into AMBOSS's clinical decision support platform, combining NEJM's evidence-based content with AMBOSS's AI-powered tools to enhance board exam preparation and clinical practice resources for healthcare professionals.
- Novaheal A German nursing education platform acquired by AMBOSS in October 2024, specializing in nursing student and professional learning resources. Strengthens AMBOSS's position in the nursing sector and expands its healthcare education ecosystem beyond medicine into nursing.
Quantifiable outcome
- Students who used AMBOSS as primary Qbank scored 10.4 points higher on USMLE Step 2 CK
- +3 more outcomes
Companies that use AMBOSS
Customer profileNamed customers11 records
Segments6 records
Ideal customer profiles4 records
AMBOSS technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability6 records
Feature10 records
AMBOSS partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- NovahealcoreAMBOSS acquired Novaheal, a German EdTech startup specializing in nursing education platforms. The acquisition strengthens AMBOSS's position in the nursing sector and expands its offerings in healthcare education, creating a comprehensive ecosystem for healthcare professionals in medicine and nursing.
- NEJM GroupcoreAMBOSS acquired NEJM Knowledge+ from NEJM Group, integrating it into its clinical decision support platform. The acquisition aims to unify board exam preparation and clinical practice tools for healthcare professionals, combining NEJM's evidence-based content with AMBOSS's AI-powered platform.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
AMBOSS competitors and assessment
Company assessmentDirect peers
- UWorld: UWorld is the dominant USMLE/medical board Qbank provider with deep penetration among US medical students. It is AMBOSS's closest direct competitor in exam preparation, with comparable question banks and similar student-facing subscription pricing.
- UpToDate (Wolters Kluwer): UpToDate is the leading point-of-care clinical decision support reference used by hospitals and clinicians worldwide. AMBOSS's AI Mode Clinical Care and Knowledge Library directly compete for the same clinician mindshare at the point of care.
- Lecturio: Lecturio is a medical education platform offering video lectures, Qbanks, and clinical learning content for medical students and professionals. It competes with AMBOSS on integrated exam prep + clinical knowledge across similar student and institutional segments.
- Osmosis (Elsevier): Osmosis, now part of Elsevier, provides video-based medical education and clinical learning for students and professionals. It overlaps with AMOSS's Knowledge Library and AI Mode Learning, especially in pre-clerkship and foundational content.
- TrueLearn: TrueLearn provides smart banks and analytics for USMLE, COMLEX, and medical board exams, with similar Qbank + performance analytics positioning to AMBOSS. It is a direct competitor in the medical Qbank market.
- Board Vitals: Board Vitals offers Qbanks and board prep for medical, nursing, and dental specialties. It overlaps with AMBOSS's board certification prep (ABIM, ABFM, PANCE, nursing) offerings and serves a similar clinician learner segment.
- DynaMed (EBSCO): DynaMed is an evidence-based clinical decision support tool used at the point of care by clinicians. It competes with AMBOSS's Clinical Reference and AI Mode Clinical Care for clinician attention in hospital and ambulatory workflows.
Broad incumbents
- Kaplan (test prep): Kaplan is a large incumbent in standardized test preparation (USMLE, MCAT, NCLEX) and offers broader professional education beyond medicine. It is a broad competitor in the medical student test prep market where AMBOSS competes.
- AccessMedicine (McGraw Hill): AccessMedicine is McGraw Hill's medical reference platform offering textbooks, Qbank, and clinical resources through institutional licensing. It is a broad incumbent competitor to AMBOSS in medical school library subscriptions.
Emerging players
- Sketchy Medical: Sketchy uses visual storytelling for medical education (microbiology, pharmacology, pathology). It is widely used by the same medical student audience and overlaps with AMBOSS's Knowledge Library in foundational content delivery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
AMBOSS social profiles
Digital presenceAMBOSS compliance and trust
Trust signalCompliance1 record
AMBOSS financial estimates
Financial estimateRevenue estimate
Valuation estimate
AMBOSS leadership team
Management profileNumber of profiles
Profiles7 records
AMBOSS subsidiaries and ownership
Company hierarchySubsidiaries3 records
AMBOSS funding detail
Funding detailFunding overview
Funding rounds5 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AMBOSS M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AMBOSS
What does AMBOSS do?
AMBOSS is a digital medical knowledge platform that combines a comprehensive Knowledge Library of 20,000+ expert-reviewed medical topics with an integrated Qbank of 4,100+ exam-preparation questions, AI-powered learning and clinical decision support tools (LiSA 1.0), and specialized offerings for medical students, physician assistant students, nurse practitioner students, and practicing clinicians. The platform supports USMLE, COMLEX, PANCE, ANCC, and board certification exam preparation alongside point-of-care clinical reference, distributed via web, mobile apps, and institutional licenses.
Is AMBOSS a public or private company?
AMBOSS is a private company. It is classified as venture growth investor backed and is currently operating.
When was AMBOSS founded?
AMBOSS was founded in 2012. It employs 501 to 1,000 people.
Where is AMBOSS based?
AMBOSS is headquartered in Berlin, Germany, in the Europe region.
How does AMBOSS make money?
Three revenue lines are on record. Individual Subscriptions are the primary driver. The others are institutional Licensing and group Discounts.
Who are AMBOSS's main competitors?
Direct peers on record are UWorld, UpToDate (Wolters Kluwer), Lecturio, Osmosis (Elsevier), TrueLearn, Board Vitals and DynaMed (EBSCO). Broad incumbents are Kaplan (test prep) and AccessMedicine (McGraw Hill). Sketchy Medical is listed as an emerging player.
Does AMBOSS have an API?
No public API is recorded for AMBOSS.
What industry is AMBOSS in?
AMBOSS's product category is Medical Education Software. Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of EDANAIAB, Nursing & Allied Health Certification Prep (CNA, EMT/Paramedic, Radiology, Sonography, PT/OT). Its NAICS code is 611710 and its SIC code is 7372.